Pure red cell aplasia caused by D-penicillamine treatment of rheumatoid arthritis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1903031.
- Also identified by PMC identifier 1004397.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 40 year old woman with rheumatoid arthritis developed pure red cell aplasia after treatment with D-penicillamine 500 mg/day. D-Penicillamine was stopped and short term treatment with steroids resulted in complete recovery of bone marrow.
Medical subject headings
- Arthritis, Rheumatoid
- Penicillamine
- Red-Cell Aplasia, Pure